Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease.
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Feb 2018 Status changed from recruiting to completed.
- 15 Dec 2006 New trial record.